Parent Category: Laboratoires Published: Friday, 17 February 2012

Operational Research on AIDS and Infectious Diseases





 TransVIHMI - UMI 223

 911, avenue Agropolis, 34394 Montpellier


Phone: +33 4 67 41 62 97







UMI 233 is a multidisciplinary research unit. The team « operational research » is conducting clinical trials, epidemiological and intervention studies on AIDS and Tropical Diseases.

Eric Delaporte is co-coordinator of the Cameroonian ANRS Site where more than 20 studies are ongoing. For instance with the co-support of EDCTP(EU) the team is PI of an important clinical trial evaluating different strategies of second line treatment for HIVin five african countries. With the support of ESTHER (jumelage hospitalier impliquant le CHU de Montpellier) and ANRS the team is PI of intervention programs to improve access to HIV care in developing countries.

Recently the team (Michel Boussinesq) received an important grant from the Gates Foundation to evaluate a new strategy to eradicate filariosis in Central Africa.


Keywords: AIDS in Developing Countries, clinical trial, resistance, emerging diseases, tropical diseases, operational research



Last publications


  • Aghokeng AF, Kouanfack C, Peeters M, Mpoudi-Ngole E, and Delaporte E Successful Integrase Inhibitor-Based Highly Active Antiretroviral Therapy for a Multidrug-Class-Resistant HIV Type 1 Group O-Infected Patient in Cameroon. AIDS Res Hum Retroviruses (2013); 29(1):1-3.
  • Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti J-P, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP, and for AESG Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon - Data from the STRATALL ANRS 12110/ESTHER trial. AIDS Care (2013); 25(3):347-355.
  • Assane Diouf, Amandine Cournil, Khadidiatou Ba-Fall, Ndèye Fatou Ngom-Guèye, Sabrina Eymard-Duvernay, Ibrahima Ndiaye, Gilbert Batista, Papa Mandoumbé Guèye, Pape Samba Bâ, Bernard Taverne, Eric Delaporte, and Papa Salif Sow Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors. ISRN AIDS (2012); 2012(Article ID 621565):8 pages.
  • Ayouba A, Mouacha F, Learn GH, Mpoudi-Ngole E, Rayner JC, Sharp PM, Hahn BH, Delaporte E, and Peeters M Ubiquitous Hepatocystis infections, but no evidence of Plasmodium falciparum-like malaria parasites in wild greater spot-nosed monkeys (Cercopithecus nictitans). Int J Parasitol (2012); 42(8):709-13.
  • Bertout S, Drakulovski P, Kouanfack C, Krasteva D, Ngouana T, Dunyach-Remy C, Dongtsa J, Aghokeng A, Delaporte E, Koulla-Shiro S, Reynes J, and Mallie M Genotyping and antifungal susceptibility testing of Cryptococcus neoformans isolates from Cameroonian HIV-positive adult patients. Clin Microbiol Infect (2012 Sep 1. [Epub ahead of print]).
  • Calmy A, Balestre E, Bonnet F, Boulle A, Sprinz EE, Wood R, Delaporte E, Messou E, McIntyre J, Marhoum El Filaili K, Schechter M, Kumarasamy N, Bangsberg D, McPhail P, Van Der Borght S, Zala C, Egger M, Thiebaut R, and Dabis F Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings. BMC Infect Dis (2012); 12(1):147.
  • Chen S, Cai W, He J, Vidal N, Lai C, Guo W, He H, Chen X, Fu L, Peeters M, Delaporte E, Andrieu J-M, and Lu W Molecular Epidemiology of Human Immunodeficiency Virus Type 1 in Guangdong Province of Southern China. PLoS ONE (2012); 7(11):e48747.
  • Cournil A, Eymard-Duvernay S, Diouf A, Moquet C, Coutherut J, Ngom Gueye NF, Cames C, Taverne B, Bork K, Sow PS, and Delaporte E Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal. PLoS One (2012); 7(2):Epub 2012 Feb 16.
  • De Beaudrap P, Thiam M, Diouf A, Toure-Kane C, Ngom-Gueye NF, Vidal N, Mboup S, Ndoye I, Sow PS, and Delaporte E Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort. J Acquir Immune Defic Syndr (2012 Oct 31. [Epub ahead of print]).
  • Diouf A, Cournil A, Ba-Fall K, Ngom G, Ndèye, Fatou, Eymard-Duvernay S, Ndiaye I, Batista G, Guèye PM, Bâ PS, Taverne B, Delaporte E, and Sow PS Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors. ISRN AIDS (2012); 2012:8.
  • Djoko CF, Wolfe ND, Aghokeng AF, Lebreton M, Liegeois F, Tamoufe U, Schneider BS, Ortiz N, Mbacham WF, Carr JK, Rimoin AW, Fair JN, Pike BL, Mpoudi-Ngole E, Delaporte E, Burke DS, and Peeters M Failure to Detect Simian Immunodeficiency Virus Infection in a Large Cameroonian Cohort with High Non-human Primate Exposure. Ecohealth (2012); 9(1):17-23.
  • Etienne L, Locatelli S, Ayouba A, Esteban A, Butel C, Liegeois F, Aghokeng A, Delaporte E, Mpoudi Ngole E, and Peeters M Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated Western lowland gorillas in cameroon. J Virol (2012); 86(18):9760-72.
  • Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngole E, Ducos J, Delaporte E, and Laurent C Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antivir Ther (2012); 17(2):321-6.
  • Laurent C, Kouanfack C, Molinari N, Koulla-Shiro S, and Delaporte E HIV laboratory monitoring for effective ART in Africa - Authors' reply. Lancet Infect Dis (2012); 12(6):430-431.
  • Liegeois F, Vella C, Eymard-Duvernay S, Sica J, Makosso L, Mouinga-Ondeme A, Mongo AD, Boue V, Butel C, Peeters M, Gonzalez JP, Delaporte E, and Rouet F Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon. J Int AIDS Soc (2012); 15(2):17985.
  • Mben JM, Kouanfack C, Essomba CN, Mbougua JB, Kenfack A, Tonfack CA, Laborde-Balen G, Bourgeois A, Biwole-Sida M, Delaporte E, and Laurent C Operational research and HIV policy and guidelines: Lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon. J Public Health Policy (2012); 33(4):462-77.
  • Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, Delaporte E, Spire B, Laurent C, and Carrieri MP Adherence as a Predictor of Sexual Behaviors in People Living with HIV/AIDS during the First Year of Antiretroviral Therapy in Rural Cameroon: Data from Stratall ANRS 12110/ESTHER Trial. PloS one (2012); 7(6):e36118.
  • Peeters M, and Delaporte E Simian retroviruses in African apes. Clin Microbiol Infect (2012); 18(6):514-20.
  • Vidal N, Diop H, Montavon C, Butel C, Bosch S, Ngole EM, Toure-Kane C, Mboup S, Delaporte E, and Peeters M A novel multiregion hybridization assay reveals high frequency of dual inter-subtype infections among HIV-positive individuals in Cameroon, West Central Africa. Infect Genet Evol (2012); ( ).

logo um 2020 rouge RVB Logo MUSE EN Original  LOGO Investirlavenir CMJN1 copie Inserm CNRS logo IRD 2016 BLOC FR COUL a partir de 2017